• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在家族性帕金森病的中脑类器官模型中,α-突触核蛋白病理学与星形胶质细胞衰老相关。

Alpha-synuclein pathology is associated with astrocyte senescence in a midbrain organoid model of familial Parkinson's disease.

作者信息

Muwanigwa Mudiwa N, Modamio-Chamarro Jennifer, Antony Paul M A, Gomez-Giro Gemma, Krüger Rejko, Bolognin Silvia, Schwamborn Jens C

机构信息

Developmental and Cellular Biology, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, L-4367 Belvaux, Luxembourg.

Bioimaging Platform, Luxembourg Centre for Systems Biomedicine, University of Luxembourg, L-4367 Belvaux, Luxembourg.

出版信息

Mol Cell Neurosci. 2024 Mar;128:103919. doi: 10.1016/j.mcn.2024.103919. Epub 2024 Feb 1.

DOI:10.1016/j.mcn.2024.103919
PMID:38307302
Abstract

Parkinson's disease (PD) is a complex, progressive neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta in the midbrain. Despite extensive research efforts, the molecular and cellular changes that precede neurodegeneration in PD are poorly understood. To address this, here we describe the use of patient specific human midbrain organoids harboring the SNCA triplication to investigate mechanisms underlying dopaminergic degeneration. Our midbrain organoid model recapitulates key pathological hallmarks of PD, including the aggregation of α-synuclein and the progressive loss of dopaminergic neurons. We found that these pathological hallmarks are associated with an increase in senescence associated cellular phenotypes in astrocytes including nuclear lamina defects, the presence of senescence associated heterochromatin foci, and the upregulation of cell cycle arrest genes. These results suggest a role of pathological α-synuclein in inducing astrosenescence which may, in turn, increase the vulnerability of dopaminergic neurons to degeneration.

摘要

帕金森病(PD)是一种复杂的、进行性神经退行性疾病,其特征是中脑黑质致密部多巴胺能神经元丧失。尽管进行了广泛的研究,但PD神经退行性变之前的分子和细胞变化仍知之甚少。为了解决这个问题,我们在此描述了使用携带SNCA三倍体的患者特异性人类中脑类器官来研究多巴胺能变性的潜在机制。我们的中脑类器官模型概括了PD的关键病理特征,包括α-突触核蛋白的聚集和多巴胺能神经元的逐渐丧失。我们发现,这些病理特征与星形胶质细胞中衰老相关细胞表型的增加有关,包括核纤层缺陷、衰老相关异染色质灶的存在以及细胞周期停滞基因的上调。这些结果表明病理性α-突触核蛋白在诱导星形胶质细胞衰老中起作用,这反过来可能会增加多巴胺能神经元对变性的易感性。

相似文献

1
Alpha-synuclein pathology is associated with astrocyte senescence in a midbrain organoid model of familial Parkinson's disease.在家族性帕金森病的中脑类器官模型中,α-突触核蛋白病理学与星形胶质细胞衰老相关。
Mol Cell Neurosci. 2024 Mar;128:103919. doi: 10.1016/j.mcn.2024.103919. Epub 2024 Feb 1.
2
Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.在基于人诱导多能干细胞的家族性帕金森病模型中展示大脑区域特定神经元易损性。
Hum Mol Genet. 2020 May 8;29(7):1180-1191. doi: 10.1093/hmg/ddaa039.
3
Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.α-突触核蛋白致密聚集体的耗散与一种新的帕金森病模型中多巴胺能神经元功能障碍和死亡的挽救有关。
Acta Neuropathol. 2019 Oct;138(4):575-595. doi: 10.1007/s00401-019-02023-x. Epub 2019 May 31.
4
Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson's disease patient (PARK4) with SNCA triplication.帕金森病患者(PARK4)中 SNCA 三重复制诱导多能干细胞源性多巴胺能神经元中的α-突触核蛋白动力学。
FEBS Open Bio. 2021 Feb;11(2):354-366. doi: 10.1002/2211-5463.13060. Epub 2021 Jan 5.
5
Single-cell transcriptomics identifies perturbed molecular pathways in midbrain organoids using α-synuclein triplication Parkinson's disease patient-derived iPSCs.单细胞转录组学使用α-突触核蛋白三倍体帕金森病患者来源 iPSCs 鉴定中脑类器官中失调的分子途径。
Neurosci Res. 2023 Oct;195:13-28. doi: 10.1016/j.neures.2023.06.001. Epub 2023 Jun 3.
6
Cell senescence induced by toxic interaction between α-synuclein and iron precedes nigral dopaminergic neuron loss in a mouse model of Parkinson's disease.α-突触核蛋白与铁的毒性相互作用诱导的细胞衰老先于帕金森病小鼠模型黑质多巴胺能神经元的丢失。
Acta Pharmacol Sin. 2024 Feb;45(2):268-281. doi: 10.1038/s41401-023-01153-z. Epub 2023 Sep 6.
7
Lipid accumulation drives cellular senescence in dopaminergic neurons.脂滴堆积导致多巴胺能神经元衰老。
Aging (Albany NY). 2024 Jul 19;16(14):11128-11133. doi: 10.18632/aging.206030.
8
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.MHC 类 II 转录激活因子调节帕金森病体内大鼠模型中种子化的α-突触核蛋白病理和多巴胺能神经退行性变。
Brain Behav Immun. 2021 Jan;91:369-382. doi: 10.1016/j.bbi.2020.10.017. Epub 2020 Oct 22.
9
Depressive-like phenotype induced by AAV-mediated overexpression of human α-synuclein in midbrain dopaminergic neurons.AAV 介导的人α-突触核蛋白过表达诱导中脑多巴胺神经元产生抑郁样表型。
Exp Neurol. 2015 Nov;273:243-52. doi: 10.1016/j.expneurol.2015.09.002. Epub 2015 Sep 9.
10
Glucocerebrosidase Gene Therapy Induces Alpha-Synuclein Clearance and Neuroprotection of Midbrain Dopaminergic Neurons in Mice and Macaques.葡萄糖脑苷脂酶基因治疗可诱导小鼠和食蟹猴脑黑质多巴胺能神经元清除和神经保护。
Int J Mol Sci. 2021 May 1;22(9):4825. doi: 10.3390/ijms22094825.

引用本文的文献

1
The current approaches to modeling the brain ischemia-reperfusion and inflammation: from animal models toward vascularized and neuroimmune cerebral organoids.目前模拟脑缺血再灌注和炎症的方法:从动物模型到血管化和神经免疫性脑类器官。
Rev Neurosci. 2025 May 28. doi: 10.1515/revneuro-2025-0015.
2
Generation of Neural Organoids and Their Application in Disease Modeling and Regenerative Medicine.神经类器官的生成及其在疾病建模和再生医学中的应用。
Adv Sci (Weinh). 2025 Aug;12(29):e01198. doi: 10.1002/advs.202501198. Epub 2025 May 24.
3
Human cerebral organoids: Complex, versatile and human-relevant models of neural development and brain diseases.
人类大脑类器官:神经发育和脑部疾病的复杂、多功能且与人类相关的模型。
Neural Regen Res. 2025 May 6. doi: 10.4103/NRR.NRR-D-24-01639.
4
α-Synuclein Pathology Spreads in a Midbrain-Hindbrain Assembloid Model.α-突触核蛋白病理学在中脑-后脑类器官模型中扩散。
Adv Sci (Weinh). 2025 May;12(20):e2409040. doi: 10.1002/advs.202409040. Epub 2025 Apr 17.
5
Exploring organoid and assembloid technologies: a focus on retina and brain.探索类器官和组装体技术:聚焦于视网膜和大脑。
Expert Rev Mol Med. 2025 Mar 27;27:e14. doi: 10.1017/erm.2025.9.
6
A Comprehensive Review on Utilizing Human Brain Organoids to Study Neuroinflammation in Neurological Disorders.利用人脑类器官研究神经疾病中的神经炎症的综合综述。
J Neuroimmune Pharmacol. 2025 Feb 22;20(1):23. doi: 10.1007/s11481-025-10181-x.
7
Alanine and glutathione targeting of dopamine- or ibuprofen-coupled polypeptide nanocarriers increases both crossing and protective effects on a blood-brain barrier model.对多巴胺或布洛芬偶联的多肽纳米载体进行丙氨酸和谷胱甘肽靶向,可增强其对血脑屏障模型的穿透作用和保护作用。
Fluids Barriers CNS. 2025 Feb 19;22(1):18. doi: 10.1186/s12987-025-00623-2.
8
Human midbrain organoids: a powerful tool for advanced Parkinson's disease modeling and therapy exploration.人源中脑类器官:用于帕金森病高级建模和治疗探索的强大工具。
NPJ Parkinsons Dis. 2024 Oct 20;10(1):189. doi: 10.1038/s41531-024-00799-8.
9
Experimental Cell Models for Investigating Neurodegenerative Diseases.用于研究神经退行性疾病的实验细胞模型。
Int J Mol Sci. 2024 Sep 9;25(17):9747. doi: 10.3390/ijms25179747.
10
Therapeutic Transplantation of Human Central Nervous System Organoids for Neural Reconstruction.人中枢神经系统类器官的治疗性移植用于神经重建。
Int J Mol Sci. 2024 Aug 5;25(15):8540. doi: 10.3390/ijms25158540.